510(k) Report

510(k) · Cleared

Cleared

Sorbastace

K965034510(k) TraditionalCleared Apr 9, 1998478-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hemostace, LLC · QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics

Cleared on Apr 9, 1998 after a 478-day review. The FDA summary names its predicate without a number. 52 later devices descend from it.

Decided
Apr 9, 1998
Review
478 days
Class
Class U
Product code
QSY
Recalls
None
Predicates
0

52 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2007: 3 descendants cleared2002: 1 descendant cleared2004: 1 descendant cleared2009: 5 descendants cleared2008: 2 descendants cleared2010: 4 descendants cleared2013: 3 descendants cleared2011: 2 descendants cleared2018: 4 descendants cleared2016: 3 descendants cleared2022: 2 descendants cleared2017: 1 descendant cleared2024: 3 descendants cleared2012: 1 descendant cleared2026: 3 descendants cleared2023: 5 descendants cleared2014: 2 descendants cleared2015: 3 descendants cleared2025: 2 descendants cleared2019: 1 descendant cleared2020: 1 descendant cleared1995200020052010201520202025
  1. This deviceK965034 SorbastaceHemostace, LLC · 1998
  2. Descendant · cites it directly · 40 of its ownK021581 HemosorbOn Site Gas Systems, Inc. · 2002
  3. Descendant · 2 generations on · 38 of its ownK070010 Quikclot Sport and Quikclot Sport SilverZ-Medica Corporation · 2007
  4. Descendant · 3 generations on · 36 of its ownK072474 Quikclot EXZ-Medica Corporation · 2007 · Recalled
  5. Descendant · 4 generations on · 20 of its ownK090026 Chitogauze, Models 130, 131, 263, 264, 265, 266Hem Con Medical Technologies, Inc. · 2009
  6. Descendant · cites it directly · 17 of its ownK070520 Pro QR (Quick Relief) Powder (for Minor External Bleeding From…Biolife, LLC · 2007

Showing 5 of 52 descendants. See all descendants

Descendants cleared per year

2002: 12004: 12007: 32008: 22009: 52010: 42011: 22012: 12013: 32014: 22015: 32016: 32017: 12018: 42019: 12020: 12022: 22023: 52024: 32025: 22026: 3
2002high 5 (2009) · low 0 (2003)2026

Most influential descendants

Showing 5 of 52 · See all
  • K021581HemosorbOn Site Gas Systems, Inc. · 2002 · cites it directly40descendants
  • K070010Quikclot Sport and Quikclot Sport SilverZ-Medica Corporation · 2007 · 2 generations on38descendants
  • K072474Quikclot EXZ-Medica Corporation · 2007 · 3 generations on36descendants
  • K090026Chitogauze, Models 130, 131, 263, 264, 265, 266Hem Con Medical Technologies, Inc. · 2009 · 4 generations on20descendants
  • K070520Pro QR (Quick Relief) Powder (for Minor External Bleeding From Wounds & Procedures)Biolife, LLC · 2007 · cites it directly17descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K965034SorbastaceHemostace, LLC1998—
+1K021581HemosorbOn Site Gas Systems, Inc.2002—
+2K070010Quikclot Sport and Quikclot Sport SilverZ-Medica Corporation2007—
+3K072474Quikclot EXZ-Medica Corporation20071
+4K090026Chitogauze, Models 130, 131, 263, 264, 265, 266Hem Con Medical Technologies, Inc.2009—
+1K070520Pro QR (Quick Relief) Powder (for Minor External Bleeding From Wounds &…Biolife, LLC2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
200410
200730
200820
200950
201040
201120
201210
201330
201420
201530
201630
201710
201840
201910
202010
202220
202350
202430
202520
202630
FIG. 1 — Lineage of K965034, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QSY device

  1. #1 K240713 Traumagel®score 15.0 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Iodosorb Powder
Named without a submission number
—
*—Intrasite Cavity Wound Dressing
Named without a submission number
—
*—Kaltostat Wound Dressing
Named without a submission number
—
*—ClearSite Hydrogel Wound Dressing
Named without a submission number
—
*—DeRoyal Hydrogel Dressing
Named without a submission number
—

What descends from it? (52)

See all 52

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K021581HemosorbOn Site Gas Systems, Inc.200240
K070520Pro QR (Quick Relief) Powder (for Minor External Bleeding From Wounds & Procedures)Biolife, LLC200717

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K021581 (On Site Gas Systems, Inc., 2002) has gone furthest, with 40 descendants of its own.

How does its category compare?

All QSY devices

QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · QSY

2in 2025

2007: 132008: 72009: 92010: 72011: 82012: 72013: 32014: 62015: 62016: 52017: 12018: 52019: 42020: 12021: 12022: 22023: 72024: 42025: 22026 (partial year): 2
2007high 13 (2007) · low 1 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QSY

142in 2024

2007: 63 days median2008: 61 days median2009: 55 days median2010: 75 days median2011: 137 days median2012: 239 days median2013: 161 days median2014: 249 days median2015: 171 days median2016: 161 days median2018: 186 days median2019: 336 days median2023: 586 days median2024: 142 days median
2007high 586 (2023) · low 55 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QSY

No recall names QSY since 2007.

Adverse event reports per year · QSY

14in 2025

2022: 12024: 32025: 14
2007high 14 (2025) · low 0 (2007)2025

MAUDE reports naming product code QSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007136300
200876100
200995500
201077500
2011813700
2012723900
2013316100
2014624900
2015617100
2016516100
20171—00
2018518600
2019433600
20201—00
20211—00
20222—01
2023758600
2024414203
20252—014
20262—0—

What is it indicated for?

Sorbastace is indicated for use to absorb body fluid and to stop minor bleeding in

fresh traumatic superficial lacerations or wounds. Once exudation and bleeding

has stopped, it is irrigated from the wound and a protective dressing can be

applied. It is intended to be distributed as an Over-The-Counter (OTC) device.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K965034: Sorbastace.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K965034

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026